AVR 3.10% $17.20 anteris technologies ltd

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-548

  1. 3,546 Posts.
    lightbulb Created with Sketch. 151
    Hi jag142

    As stated in the last announcement on the 1 March;

    “After our initial positive experience with ADAPT® we are excited to have the choice of these 3D shaped products that will produce better reconstructions for complex aortic arch repair surgeries,” said Professor Tomasz Mroczek, from the Department of Paediatric Cardiac Surgery, University Children's Hospital, Jagiellonian University Medical College in Kraków, Poland.
    -----------------------------

    Great to see them starting to use them straight away or soon after getting EU approval and if the Professor has his way, Admedus could be sending a heap more of the ADAPT products their way.
    They do about 365 open heart surgeries p.a at the Krakow Childrens Hospital.
    Just maybe this could help the snowball to start picking up speed.....it would certainly be welcome.

    Regards
    Dabru

    Last edited by Dabru: 04/04/19
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$17.20
Change
-0.550(3.10%)
Mkt cap ! $330.6M
Open High Low Value Volume
$17.75 $17.75 $16.88 $199.1K 11.56K

Buyers (Bids)

No. Vol. Price($)
1 500 $17.00
 

Sellers (Offers)

Price($) Vol. No.
$17.24 1000 1
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.